Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.
IL-4 and IL-13 have distinct and overlapping roles with a broad impact on CRSwNP symptoms.
.png/jcr:content/image%20(92).png)
.png0/jcr:content/1%20(2).png)
.png/jcr:content/2%20(3).png)
.png0/jcr:content/3%20(2).png)
MAT-BH-2400335/v1/May2024
Campus
IL-4 and IL-13 have distinct and overlapping roles with a broad impact on CRSwNP symptoms.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.